Wellbeing Digital Sciences Inc. (KONEF)
| Market Cap | 163.00 -90.0% |
| Revenue (ttm) | 5.03M +469.4% |
| Net Income | -19.67M |
| EPS | -0.16 |
| Shares Out | 163.22M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Open | 0.000001 |
| Previous Close | 0.000001 |
| Day's Range | 0.000001 - 0.000001 |
| 52-Week Range | 0.000001 - 0.000001 |
| Beta | 33.88 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About KONEF
Wellbeing Digital Sciences Inc., a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. The company was formerly known as KetamineOne Capital Limited and changed its name to Wellbeing Digital Sciences Inc. in January 2022. Wellbeing Digital Sciences Inc. was founded in 2017 and is headquartered in Vancouver, Canada. [Read more]
News
Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $KONEF #psychedelics--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental heal...
Wellbeing Digital Enters into Share Purchase Agreement with Cardinal Group
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $KONEF #psychedelics--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental heal...
Wellbeing Digital Subsidiary KGK Science to Participate at the Nutrition Industry Association Spring Conference
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $KONEF #psychedelics--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental heal...
Wellbeing Subsidiary KGK Science Announces Successful Results of UP360, a Nutraceutical Ingredient Demonstrating Beneficial Immune Defense Response
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $KONEF #psychedelics--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental heal...
Wellbeing Subsidiary KGK Science Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $KONEF #psychedelics--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental heal...
Wellbeing Subsidiary KGK Science Receives Institutional Review Board Approval
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $KONEF #psychedelics--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental heal...
Wellbeing Announces Cease Trade Order
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $KONEF #psychedelics--Wellbeing Digital Sciences Inc.
Wellbeing Provides Bi-Weekly Default Status Report
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $KONEF #psychedelics--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2) is providing this update with ...
Wellbeing Digital to Participate at the Cantor Fitzgerald Virtual Panel Discussion
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $KONEF #psychedelics--Wellbeing Digital Sciences Inc.
Wellbeing Digital to Participate in The Global Biomedical Design Conference
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $KONEF #psychedelics--Wellbeing Digital Sciences Inc.
Wellbeing Subsidiary KGK Science Applies for a Controlled Substances Dealers License and Receives Approval to Proceed with Buildout
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $KONEF #psychedelics--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental heal...
Wellbeing Subsidiary KGK Science Announces Publication of Safety Studies on Paraxanthine and Comparison to Caffeine Toxicity.
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $KONEF #psychedelics--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental heal...
Wellbeing Subsidiary KGK Science Receives Exemption Under Section 56 of the Controlled Drugs and Substances Act to Begin Psilocybin Clinical Trial
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $KONEF #psychedelics--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental heal...
Wellbeing Announces Delay in Filing Its Financial Statements and Management Cease Trade Order
VANCOUVER, British Columbia--(BUSINESS WIRE)--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused ...
Wellbeing Digital to Participate in the Psychedelic Medicine Association Webinar
VANCOUVER, British Columbia--(BUSINESS WIRE)--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused ...
Wellbeing Digital Announces Change of Auditor
VANCOUVER, British Columbia--(BUSINESS WIRE)--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused ...
Wellbeing Subsidiary KGK Science Receives Approval for First-of-its-Kind Psylocibin Clinical Trial
VANCOUVER, British Columbia--(BUSINESS WIRE)--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused ...
Wellbeing Subsidiary KGK Science Awarded Cannabis Research License from Health Canada
VANCOUVER, British Columbia--(BUSINESS WIRE)--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused ...
Wellbeing Subsidiary KGK Science Announces Successful Results of UP446, a Nutraceutical Ingredient, in Positive Immune Defense Response
VANCOUVER, British Columbia--(BUSINESS WIRE)--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused ...
Wellbeing Subsidiary KGK Science Submits CTA for Phase IIA Clinical Trial
VANCOUVER, British Columbia--(BUSINESS WIRE)--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused ...
Wellbeing Subsidiary Mindscape Treats its 1,000th Patient
VANCOUVER, British Columbia--(BUSINESS WIRE)--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused ...
Wellbeing Digital Announces the Appointment of Mohammad Sharifi to Board of Directors
VANCOUVER, British Columbia--(BUSINESS WIRE)--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused ...
Wellbeing Digital Announces Resignation of Directors
VANCOUVER, British Columbia--(BUSINESS WIRE)--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused ...
Wellbeing Subsidiary KGK Science Enters into Research Contract With Nova Mentis for Phase II A Clinical Trial
VANCOUVER, British Columbia--(BUSINESS WIRE)--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused ...
Wellbeing Subsidiary KGK Science Announces Successful Delivery of CBD and THC Through the Skin of Healthy Volunteers
VANCOUVER, British Columbia--(BUSINESS WIRE)--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused ...